biotech
biotech Articles
Adverum Biotechnologies shares made a handy gain on Thursday after the company announced a key update from the FDA.
Published:
Last Updated:
Clovis shares might not be showing it now, but the company is facing some heat from the SEC over charges of misleading investors about the company’s developmental lung cancer drug.
Published:
Last Updated:
Viking Therapeutics shares more than doubled on Tuesday after the company announced results from its mid-stage non-alcoholic fatty liver disease trial.
Published:
Last Updated:
CRISPR Therapeutics shares dipped on Monday after the company announced a collaboration with ViaCyte focused on the discovery, development and commercialization of gene-edited allogeneic stem cell...
Published:
Last Updated:
Clinical-stage biopharmaceutical company Urovant Sciences intends to price 10 million shares for an initial public offering valued up to $184 million.
Published:
Last Updated:
Principia Biopharma now intends to price more than 6 million shares for an initial public offering valued up to more than $122 million.
Published:
Last Updated:
Clinical-stage immuno-oncology company Allogene Therapeutics has filed with the SEC in regards to its initial public offering.
Published:
Last Updated:
Acorda Therapeutics shares dipped on Thursday after the company announced that the FDA would be delaying its Prescription Drug User Fee Act goal date for its review of the New Drug Application of...
Published:
Last Updated:
Progenics Pharmaceuticals shares dropped on Thursday after the company announced late-stage results from its prostate cancer study.
Published:
Last Updated:
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The August 31 short interest data have been compared with the previous report, and short interest in...
Published:
Last Updated:
Vital Thearpies shares were absolutely crushed on Wednesday after the company announced less-than-favorable results for its liver failure trial.
Published:
Last Updated:
Gilead shares were up handily on Wednesday after the company announced that it had entered into a strategic collaboration with Precision BioSciences.
Published:
Last Updated:
Foamix Pharmaceuticals shares were last seen up early on Wednesday after the company announced a solid performance in its late-stage trial for moderate-to-severe acne.
Published:
Last Updated:
Endocyte filed with the SEC for a secondary offering. In most cases where a company does this, we see the stock drop. However, in this case investors are cheering Endocyte and its secondary offering.
Published:
Last Updated:
With 2018 coming to a close in just a few months, Merrill Lynch is taking a close look at the biotech industry and what key catalysts to expect before 2019.
Published:
Last Updated: